New Monoclonal Antibody
Leading Fight on COVID-19
Bamlanivimab is a treatment option for people with COVID-19 who:
- • Age 12 or older
- • Weigh 88 piunds or more
- • Have had mild to moderate symptopms for 10 days or less
- • Are at high risk to get very sick from COVID-19
For Adults, bamlanivimab may be an option if you:
- • Age 65 or older
- • Have obesity, with a body mass index (BMI) of 35 or higher
- • Have diabetes, chronic kidney disease, or a condition that weakens the immune system
- • Take medication that weakens the immune system
- • Are age 55 or older and have heart disease, high blood pressure, or a long-term lung disease
For Pediatric patients age 12-17, bamlanivimab may be an option if you:
- • Have obesity, with a BMI higher than 85 percent of patients your same age or gender
- • Have heart disease, sickle cell disease, or a long-term lung disease
- • Have a developmental condition, like cerebral palsy
- • Regularly use medical technology, like a ventilator or feeding tube
If you are not sure if BAMLANIVIMAB is right for you, Please EMAIL us covid@dgfphysicians.com or Call 409-813-1677